CHINWAGYThe world's live brand collaboration wire
Join freeCreatorsIndustryContact
For you +
ReadersCreatorsBrands & IndustryContact Chinwagy

THE CHINWAGY BUZZ · FIRST VERIFIED WORD

Takeda and Halozyme announce global collaboration and license agreement on vedolizumab

Takeda×Halozyme Therapeutics, Inc.

WHAT CHINWAGY KNOWS

The collaboration
is confirmed.

Takeda announced a global collaboration and license agreement granting it exclusive access to Halozyme’s ENHANZE® drug-delivery technology for use with vedolizumab.

Current status
Official collaboration
Known availability
The published source describes the collaboration; timing details remain under review.
Place
Osaka; Cambridge, Japan; United States
Source checked
September 23, 2026

SHARE OR FOLLOW THE BUZZ

Keep it moving.

Share the permanent Chinwagy profile, download a branded social card or save the story so its next update stays within reach.

FOLLOW THE STORY

More details will move this intelligence into the right Chinwagy destination.